Atlas Trials

Huabo Biopharm Co., Ltd.

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Huabo Biopharm Co., Ltd.

RecordFirmDate
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC (NCT07376629)Huabo Biopharm Co., Ltd.2025-08-14
A Phase 2 Study of HB0017 in Psoriasis Patients (NCT06592274)Huabo Biopharm Co., Ltd.2024-09-30
A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor (NCT06758557)Huabo Biopharm Co., Ltd.2024-01-31
A Study of HB0025 Injection in Patients With Advanced Renal Cancer (NCT06222125)Huabo Biopharm Co., Ltd.2023-01-30
A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis (NCT05531682)Huabo Biopharm Co., Ltd.2022-10-25
A Study of HB0030 Injection in Patients With Advanced Solid Tumors (NCT05706207)Huabo Biopharm Co., Ltd.2021-12-21
A Study of HB0017 in Patients With Moderate to Severe Plaque Psoriasis (NCT05442788)Huabo Biopharm Co., Ltd.2021-09-02
A Study of of HOT1030 in Patients With Advanced Solid Tumors (NCT05060263)Huabo Biopharm Co., Ltd.2021-03-12
A Study of Injection HB0025 in Patients With Advanced Solid Tumors (NCT04678908)Huabo Biopharm Co., Ltd.2021-03-10
A Study of Injection HB0017 in Adult Healthy Volunteers (NCT04505033)Huabo Biopharm Co., Ltd.2020-10-02
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor (NCT04802980)Huabo Biopharm Co., Ltd.2020-04-28
A Study of Injection HB002.1T in Subjects With Solid Tumor (NCT03636750)Huabo Biopharm Co., Ltd.2018-06-28
A Study of Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration (NCT03387566)Huabo Biopharm Co., Ltd.2018-02-08

Track Huabo Biopharm Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.